Understanding how PARP2 affects RNA structures in blood disorders
Elucidating molecular mechanisms of PARP2 at R loops in myelodysplastic syndromes
['FUNDING_FELLOWSHIP'] · UNIVERSITY OF MINNESOTA · NIH-11070505
This study is looking at how a protein called PARP2 affects certain RNA structures in people with myelodysplastic syndromes (MDS), a blood disorder, to find new ways to help improve treatment options for patients.
Quick facts
| Phase | ['FUNDING_FELLOWSHIP'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-11070505 on ClinicalTrials.gov |
What this research studies
This research investigates the role of PARP2 in regulating R loops, which are important RNA structures, in patients with myelodysplastic syndromes (MDS). MDS is a serious blood disorder that can lead to acute myeloid leukemia, and the study focuses on how mutations in RNA splicing factors affect disease progression. By exploring the molecular mechanisms involved, the research aims to identify potential therapeutic targets that could improve patient outcomes. The approach includes laboratory experiments to analyze the interactions between PARP2 and R loops in cells with specific genetic mutations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with myelodysplastic syndromes, particularly those with mutations in RNA splicing factor genes.
Not a fit: Patients without myelodysplastic syndromes or those with different underlying causes of blood disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment strategies that improve survival and quality of life for patients with myelodysplastic syndromes.
How similar studies have performed: Previous research has shown promising results in targeting similar molecular mechanisms in blood disorders, indicating potential for success in this area.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MCMAHON, MATTHEW CHARLES — UNIVERSITY OF MINNESOTA
- Study coordinator: MCMAHON, MATTHEW CHARLES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: blood disease diagnosis, Blood Diseases, blood disorder, blood disorder diagnosis